David J. Kim, M.D., Partner

David joined Pinnacle Ventures in 2007 to lead the healthcare investment efforts. Prior to Pinnacle, David worked at MPM Capital, where he was involved with successful investments in multiple biotech and medical device companies. At MPM, he also worked closely with several portfolio companies including HemoSense (acquired by Inverness Medical), CHF Solutions (acquired by Gambro), IntraLuminal and Innovative Spinal Technologies. His other experiences in financial services include positions as a Senior Equity Analyst at Pacific Growth Equities covering medical devices, a Senior Equities Analysts for Firsthand Capital Management evaluating biotech and device companies and a Medical Device Research Associate at Banc of America Securities. David also worked as a business development intern at Compass, a business development unit of Guidant Corporation.
 
David finished his internal medicine residency at Harbor-UCLA Medical Center and practiced clinical medicine as a board certified internist. Dr. Kim received his M.D. from the Johns Hopkins University School of Medicine and his MBA from Stanford Graduate School of Business. He also graduated Cum Laude, Phi Beta Kappa and Sigma Xi from Pomona College with a BA in biology.
 
David currently serves as a board director at TriVascular and as a board observer at Access Closure.

dkim@pinnacleventures.com
(650) 926-7819